Picture of MannKind logo

MNKD MannKind News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSucker Stock

MannKind Corp reports results for the quarter ended in December - Earnings Summary

* MannKind Corp  MNKD.OQ  reported quarterly breakeven
results​​
per share for the quarter ended in December, higher than the
same quarter last year, when the company reported EPS of -7
cents.  The mean expectation of six analysts for the quarter was
for breakeven results per share. Wall Street expected results to
range from -2 cents to 4 cents per share.
    * Revenue rose 62.2% to $58.47 million from a year ago;
analysts
expected $53.58 million. 
    * MannKind Corp's reported EPS for the quarter was breakeven
results​.
    * The company reported quarterly net income of $1.4 million.
    * MannKind Corp shares had fallen by 1.6% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 47.4%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for MannKind Corp is
$6.75 
This summary was machine generated from LSEG data February 27 at
10:42 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.00           0.00           Met
 Sep. 30 2023      -0.02          0.01           Beat
 Jun. 30 2023      -0.04          -0.02          Beat
 Mar. 31 2023      -0.05          -0.04          Beat

Recent news on MannKind

See all news